A clinical review found insufficient evidence for medical cannabis efficacy or safety in children for any condition, with growing data suggesting possible harm, though specific cases like refractory epilepsy may warrant carefully monitored use.
Read this if you are a parent considering medical cannabis for a child or a clinician advising families about pediatric cannabis use.
Insufficient data to support cannabis efficacy or safety for any pediatric indication as of 2016.
What the researchers found
This clinical review examined the evidence for medical cannabis use in children, prompted by case reports of children with refractory epilepsy responding to cannabis-based treatments. The author concluded that overall evidence is insufficient to support either the efficacy or safety of cannabis use for any indication in children.
The review emphasized several concerns: an increasing body of data suggests possible harm, particularly in conditions where the developing brain may be vulnerable. Smoking is explicitly rejected as an acceptable delivery method for children. The review also cautioned that therapeutic use in specific medical cases should not be used to justify recreational cannabis use by adolescents.
Despite these concerns, the author acknowledged that exceptional cases exist where standard treatments have failed, and offered recommendations for therapeutic use in these circumstances: always under careful individual evaluation, within well-designed research studies, and with ongoing monitoring for both safety and efficacy.
Why it matters
Medical cannabis for children is among the most contentious topics in pediatric medicine. This review from a mainstream pediatric journal represents the medical establishment's cautious position: acknowledge that some children may benefit, particularly those with refractory epilepsy, but insist on rigorous evaluation and monitoring rather than broad access.
The numbers in context
No specific numerical data were presented; the review synthesized existing evidence and provided clinical recommendations.
How the study worked
This was a narrative clinical review published in Paediatrics & Child Health (a journal of the Canadian Paediatric Society), summarizing available evidence on cannabis use in pediatric populations and providing clinical recommendations.
What this study cannot tell us
This is a narrative review reflecting one author's interpretation of available evidence, published before many subsequent clinical trials of pharmaceutical-grade CBD products in pediatric epilepsy. The review predates the FDA approval of Epidiolex (cannabidiol) for pediatric seizure disorders.
How to read the evidence
Moderate evidence from a narrative clinical review in a reputable pediatric journal, synthesizing available data and providing consensus-oriented recommendations.
When this study was published
Published in 2016, before the FDA approved Epidiolex (CBD) for pediatric epilepsy in 2018. The evidence landscape for pediatric cannabis use has changed significantly.
The bigger picture
The tension between anecdotal reports of children with severe epilepsy responding dramatically to cannabis-based treatments and the lack of rigorous safety and efficacy data exemplifies the broader challenge of cannabis medicine. The stakes are especially high in children because of the developing brain's sensitivity to cannabinoids.
Questions still open
- Have subsequent clinical trials of pharmaceutical CBD products changed the risk-benefit calculus for children with epilepsy? Should cannabis-based treatments for children be limited to pharmaceutical-grade products with standardized dosing? How do we balance parental autonomy with medical caution when standard treatments fail?
Common questions
Is medical cannabis safe for children?
Can cannabis treat childhood epilepsy?
Read the original research
Is the medical use of cannabis a therapeutic option for children?
Paediatrics & child health, 21(1), 31-4
Citation
Rieder, Michael J. (2016). Is the medical use of cannabis a therapeutic option for children?. Paediatrics & child health, 21(1), 31-4.
Explore the wider topic
- CBD Oil Quality Guide: How to Avoid Snake Oil
- Anxiety After Quitting Weed: When to Consider Medication
- Cannabis for Chemotherapy Nausea: What the Evidence Actually Shows
- Cannabis for Chronic Pain: What the Research Actually Supports
- Cannabis and Epilepsy: The Epidiolex Story and What It Means
- Does CBD Actually Work for Anxiety? What the Evidence Shows
- Does CBD Help with Weed Withdrawal? What Studies Show
- CBD vs THC: The Differences That Actually Matter
- The Proven Medical Benefits of Cannabis: What Research Supports
- Quitting Weed Before Surgery
- Weed and Medications: What Changes When You Quit
- Quitting Weed During Pregnancy: What You Need to Know
- Quitting Weed While Pregnant: What You Need to Know
- Cannabis and Older Adults: Risks Seniors Should Know
- Cannabis and Breastfeeding: THC in Breast Milk